Approach to Hypocalcemia in Pediatric Population
In pediatric hypocalcemia, immediately assess for life-threatening symptoms (seizures, tetany, laryngospasm, QTc prolongation) and treat emergently with IV calcium gluconate if present, while simultaneously investigating the underlying cause through PTH measurement, which serves as the critical branch point for diagnosis.
Acute Management
Life-Threatening Hypocalcemia
For symptomatic hypocalcemia with albumin-corrected calcium <7.5 mg/dL (<1.9 mmol/L), immediate IV calcium gluconate is mandatory 1:
- Initial bolus: 1 g calcium gluconate (90 mg elemental calcium) IV over 10 minutes
- Pediatric dosing: 10-20 mg/kg elemental calcium (1-2 mL/kg of 10% calcium gluconate) 2
- Continuous infusion: 10 g calcium gluconate in 1 L D5W at 100 mL/h, titrated with cardiac monitoring 1
- Concurrent monitoring: Continuous cardiac monitoring for arrhythmias, QTc prolongation; watch for laryngospasm 1, 3
- Simultaneous oral therapy: Begin oral calcium and activated vitamin D immediately 1
Asymptomatic Hypocalcemia
For asymptomatic newborns and infants, elemental calcium replacement of 40-80 mg/kg/day is recommended 2.
Critical screening populations requiring calcium monitoring at 24 and 48 hours after birth 2:
- Preterm infants <32 weeks gestation
- Small for gestational age infants
- Infants of diabetic mothers
- Severe perinatal asphyxia (1-minute Apgar <4)
Diagnostic Evaluation
Initial Laboratory Assessment
The PTH level is the critical diagnostic pivot point 4, 1, 5:
Measure immediately:
- Albumin-corrected or ionized calcium (confirm on two separate occasions, at least 2 weeks apart for chronic diagnosis) 1
- PTH (2nd or 3rd generation assay)
- Serum magnesium (correct before interpreting PTH—magnesium deficiency causes PTH resistance and impaired secretion) 1
- Serum phosphate
- 25-hydroxyvitamin D
- BUN/creatinine, eGFR 4
- 12-lead EKG for QTc prolongation 1
Important caveat: Stop biotin supplementation (if >5 mg daily) for at least 3 days before PTH testing, as it interferes with some PTH assays 1.
Age-Specific Considerations
Neonatal period (first 72 hours):
- Early-onset hypocalcemia is typically asymptomatic and related to prematurity, maternal diabetes, or birth asphyxia 2
- Definitions: Total calcium <8 mg/dL (2 mmol/L) or ionized calcium <4.4 mg/dL (1.1 mmol/L) for term infants; <7 mg/dL (1.75 mmol/L) or ionized calcium <4 mg/dL (1 mmol/L) for VLBW infants <1500 g 2
Late-onset (after 72 hours to end of first week):
- Usually symptomatic
- Common causes: excessive phosphate intake, hypomagnesemia, hypoparathyroidism, vitamin D deficiency 2
Etiologic Workup Based on PTH
If PTH is low or inappropriately normal (hypoparathyroidism):
- Postsurgical: Measure PTH 12-24 hours post-thyroidectomy; if PTH <10 pg/mL (<1.05 pmol/L), close follow-up required as <50% develop permanent hypoparathyroidism. Chronic diagnosis confirmed if hypocalcemia persists ≥12 months post-surgery 1
- Genetic testing: Strongly advised for all idiopathic cases, especially with family history or age <40 years 1
- Additional studies: 1,25-dihydroxyvitamin D, 24-hour urine calcium/creatinine 4
If PTH is elevated (secondary causes):
- Vitamin D deficiency/resistance
- Renal disease
- Malabsorption
- Pseudohypoparathyroidism
Assessment for Complications 1
- Renal: 24-hour urine calcium, creatinine, oxalate, citrate; renal ultrasound
- Ocular: Eye exam for cataracts
- Neurologic: Brain CT if neuropsychiatric symptoms present and duration >5 years
- Cardiac: EKG baseline; cardiac monitoring if symptomatic
- Skeletal: Bone turnover markers, BMD with DXA (age-appropriate)
Chronic Management
Conventional Therapy (First-Line)
- Prevent symptoms of hypocalcemia
- Maintain serum calcium in low-normal range (no more than 0.5 mg/dL below normal)
- Maintain calcium-phosphate balance
- Target 24-hour urine calcium <250 mg/24h (women) or <300 mg/24h (men) 1
Calcium supplementation 1:
- Take with meals (acts as phosphate binder and improves absorption)
- Calcium citrate preferred with PPI use and may reduce urinary oxalate
- Multiple daily doses for sustained levels
Active vitamin D 1:
- Calcitriol: Start 0.25 μg daily; short half-life (5-8 hours) requires higher/divided doses
- Alfacalcidol: Start 0.5 μg daily; half-life 3-6 hours
- Follow-up in 2-3 days after dose changes
Adjunctive therapy:
- Correct 25(OH)D deficiency: Parent vitamin D (cholecalciferol/ergocalciferol) to normal range 1
- Correct magnesium: Essential for PTH secretion and action 1
- Thiazide diuretics: 25-100 mg daily for hypercalciuria, with low-sodium diet; monitor potassium and magnesium 1
- Low phosphate diet: Limit dairy, beans, meat, nuts, seeds; avoid food additives high in bioavailable phosphorus 1
Monitoring Schedule 1
- Every 3-12 months (depending on stability): Serum calcium, albumin, phosphorus, magnesium, eGFR
- Every 6-12 months: 25(OH)D (every 3 months until target achieved)
- Every 6-24 months: 24-hour urine calcium and creatinine
- Baseline only: PTH (limited value in serial monitoring)
Common Pitfalls
Failing to correct magnesium first: Hypomagnesemia causes PTH resistance and impaired secretion; PTH interpretation is unreliable until magnesium is normalized 1
Over-supplementation risks: Active vitamin D increases both serum phosphorus and urine calcium, potentially causing nephrocalcinosis, nephrolithiasis, and CKD 1
Biotin interference: High-dose biotin (>5 mg daily) falsely lowers PTH in some assays 1
Missing genetic diagnosis: Failure to test young patients or those with family history delays appropriate counseling and management 1
Inadequate neonatal screening: Missing high-risk infants who require calcium monitoring at 24 and 48 hours 2
Special Populations
Pregnancy
- Requires frequent monitoring (every 2-4 weeks)
- Stop thiazide diuretics
- Target mid-to-low normal calcium
- Recognize maternal complications: pre-eclampsia, seizures, arrhythmias, preterm labor
- Recognize fetal complications: neonatal seizures, hyperparathyroidism (if maternal calcium low), hypoparathyroidism (if maternal calcium high) 1